Sanofi said European regulators have accepted its marketing application for a quadrivalent version of its Vaxigrip flu vaccine. The new vaccine is designed to fight the four strains of flu virus anticipated in the coming season. Sanofi plans to apply for marketing approval in all countries where the three-strain Vaxigrip is currently marketed.
EU officials to review Sanofi's quadrivalent flu vaccine
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||